SKNY

LIR Life Sciences Corp. Stock Price

CNSX:SKNY Community·CA$18.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SKNY Share Price Performance

SKNY Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

LIR Life Sciences Corp. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$0

Other Expenses

CA$0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About SKNY

Founded
2024
Employees
n/a
CEO
Edward Mills
WebsiteView website
www.lirlifesciences.com

LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada.

Recent SKNY News & Updates

Recent updates

No updates